bioprosthesis


Also found in: Dictionary.

bioprosthesis

 [bi″o-pros-the´sis]
a prosthesis made of biological material.

bioprosthesis

/bio·pros·the·sis/ (-pros-the´sis) a prosthesis that contains biological material.bioprosthet´ic

bioprosthesis

Any implanted device of natural (i.e., nonsynthetic) origin designed to replace a defective body part—e.g., a porcine heart valve.

bioprosthesis

An implanted device of natural–ie, nonsynthetic origin–eg, porcine tissue designed to replace a defective body part–eg, a heart valve. See Heart-valve prosthesis.
References in periodicals archive ?
The ProCol[R] Vascular Bioprosthesis uses a mesenteric bovine vein for patients with failed AVGs who require a new access.
My goal is to help deliver a pipeline of innovative bioprosthesis systems in a more rapid fashion.
Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN Valve.
A Novel Approach to Tricuspid Valve Replacement: The Upside Down Stentless Aortic Bioprosthesis.
The aortic valve was replaced with a 25 mm Mosaic bioprosthesis.
The explanted device was a conduit with a Carpentier-Edwards porcine bioprosthesis that had been in place for 12 years.
Based on the precept that CyForm Follows Function,' the ATS 3f Aortic Bioprosthesis is a revolutionary next generation stentless pericardial aortic tissue valve that is unlike any other replacement valve, the company said.
The goal would be to delay the need for aortic valve surgery, or in patients with an existing bioprosthesis, to delay the need for a redo procedure.
has received Communaute Europeenne (CE) Mark approval for its next-generation stentless tissue valve, the Toronto Root bioprosthesis, and will begin a limited European market launch.
Noncompliance with long-term anticoagulation (Bradley, Midgley, Watson, Getson, & Scott, 1985) and high rate of degeneration of bioprosthesis due to calcium deposit (Sanders, Levy, Freed, Norwood, & Castaneda, 1980) have been identified as the two primary factors responsible for inadequate anticoagulation resulting in thromboembolic complications in children with prosthetic cardiac valves